Search results for "GONADOTROPIN-RELEASING-HORMONE"

showing 2 items of 2 documents

Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines.

2016

Summary Context Undescended testis is the most common endocrinological disease in the male newborn period. Incidence varies between 1.0% and 4.6% in full-term neonates, with rates as high as 45% in preterm neonates. Failure or delay of treatment can result in reduced fertility and/or increased testicular cancer risk in adulthood. Objective To provide recommendations for the diagnosis and treatment of boys with undescended testes which reduce the risk of impaired fertility and testicular cancer in adulthood. Evidence acquisition Embase and Pubmed were searched for all relevant publications, from 1990 to 2015 limited to English language. Data were narratively synthesized in light of methodolo…

Malemedicine.medical_specialtyBOYSNONPALPABLE TESTISUrologymedia_common.quotation_subjectmedicine.medical_treatment030232 urology & nephrologyMEDLINEUrologyFertilityContext (language use)CRYPTORCHID TESTISCHILDRENDiseaseOrchidopexy03 medical and health sciences0302 clinical medicineHUMAN CHORIONIC-GONADOTROPINTesticular cancerTESTICULAR DESCENT030225 pediatricsCryptorchidismmedicineHumansOrchiopexyTesticular cancermedia_commonGONADOTROPIN-RELEASING-HORMONEFERTILITY INDEXbusiness.industryIncidence (epidemiology)Infantmedicine.diseaseFertilityUndescended testisPediatrics Perinatology and Child HealthSURGICAL-MANAGEMENTHormonal therapybusinessORCHIOPEXYJournal of pediatric urology
researchProduct

The Concise Guide To Pharmacology 2021/22: G Protein-Coupled Receptors

2021

The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will s…

RMCytoplasmic and NuclearComputer scienceDatabases PharmaceuticalHumans; Ion Channels; Ligands; Receptors Cytoplasmic and Nuclear; Receptors G-Protein-Coupled; Databases Pharmaceutical; PharmacologyReceptors Cytoplasmic and NuclearIN-VITRO CHARACTERIZATIONPharmacologyLigandsIon ChannelsNORSlaw.inventionReceptors G-Protein-CoupledG-Protein-CoupledDatabases03 medical and health sciencesCALCIUM-SENSING RECEPTOR0302 clinical medicineDELTA-OPIOID RECEPTORlawSummary informationReceptorsHumansHISTAMINE H-3 RECEPTORFATTY-ACID RECEPTORMETABOTROPIC GLUTAMATE-RECEPTOR030304 developmental biologyG protein-coupled receptorPharmacologyGONADOTROPIN-RELEASING-HORMONE0303 health sciencesClinical pharmacologyFORMYL PEPTIDE RECEPTORMUSCARINIC ACETYLCHOLINE-RECEPTOR3. Good health317 Pharmacy030220 oncology & carcinogenesisPharmaceuticalNEGATIVE ALLOSTERIC MODULATORCatalytic receptors
researchProduct